Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1980 Jan;43(1):68–70. doi: 10.1136/jnnp.43.1.68

Platelet monoamine oxidase activity in epilepsy.

Z L Kruk, A Moffett, D F Scott
PMCID: PMC490465  PMID: 7354360

Abstract

The platelet monoamine oxidase activity (MAO) of 33 patients with epilepsy was compared with a group of neurological patients and a group of normal control subjects. We found that the MAO activity was increased significantly in the epileptic group when compared with the normal. This was not related to anticonvulsant medication. These results could be explained by the effect of epilepsy or anticonvulsant medication on the maturation of platelets.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Century B., Rupp K. L. Comment on microfluorometric determination of monoamine oxidase. Biochem Pharmacol. 1968 Sep;17(9):2012–2013. doi: 10.1016/0006-2952(68)90121-4. [DOI] [PubMed] [Google Scholar]
  2. Friedhoff A. J., Miller J. C., Karpatkin S. Heterogeneity of human platelets. VII. Platelet monoamine oxidase activity in normals and patients with autoimmune thrombocytopenic purpura and reactive thrombocytosis: its relationship to platelet protein density. Blood. 1978 Feb;51(2):317–323. [PubMed] [Google Scholar]
  3. Gabay S., Achee F. M., Mentes G. Some parameters affecting the activity of monoamine oxidase in purified bovine brain mitochondria. J Neurochem. 1976 Aug;27(2):415–424. doi: 10.1111/j.1471-4159.1976.tb12263.x. [DOI] [PubMed] [Google Scholar]
  4. HERTTING G., AXELROD J., PATRICK R. W. Actions of cocaine and tyramine on the uptake and release of H3-norepinephrine in the heart. Biochem Pharmacol. 1961 Sep;8:246–248. doi: 10.1016/0006-2952(61)90009-0. [DOI] [PubMed] [Google Scholar]
  5. KLERMAN G. L., COLE J. O. CLINICAL PHARMACOLOGY OF IMIPRAMINE AND RELATED ANTIDEPRESSANT COMPOUNDS. Pharmacol Rev. 1965 Jun;17:101–141. [PubMed] [Google Scholar]
  6. Krajl M. A rapid microfluorimetric determination of monoamine oxidase. Biochem Pharmacol. 1965 Nov;14(11):1684–1686. doi: 10.1016/0006-2952(65)90025-0. [DOI] [PubMed] [Google Scholar]
  7. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  8. Murphy D. L., Costa J. L., Shafer B., Corash L. Monoamine oxidase activity in different density gradient fractions of human platelets. Psychopharmacology (Berl) 1978 Oct 31;59(2):193–197. doi: 10.1007/BF00427757. [DOI] [PubMed] [Google Scholar]
  9. Richens A., Rowe D. J. Disturbance of calcium metabolism by anticonvulsant drugs. Br Med J. 1970 Oct 10;4(5727):73–76. doi: 10.1136/bmj.4.5727.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Swash M., Moffett A. M., Scott D. F. Tyramine activates the EEG in epileptic patients. Nature. 1975 Dec 25;258(5537):749–750. doi: 10.1038/258749a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES